Mathematical Modeling of Cytotoxic Lymphocyte-Mediated Immune Response to Hepatitis B Virus Infection

Nowak's model of the human immunodeficiency virus (HIV) infection has been extensively and successfully used to simulate the interaction between HIV and cytotoxic lymphocyte- (CTL-) mediated immune response. However, this model is not available for hepatitis B virus (HBV) infection. As the enhanced recruitment of virus-specific CTLs into the liver has been an important novel concept in the pathogenesis of hepatitis B, we develop a specific mathematical model analyzing the relationship between HBV and the CTL-mediated immune response, and the indicator of the liver cell damage, alanine aminotransferase (ALT). The stability condition of the complete recovery equilibrium point at which HBV will be eliminated entirely from the body is discussed. A different set of parameters is used in the simulation, and the results show that the model can interpret the wide variety of clinical manifestations of HBV infection. The model suggests that a rapid and vigorous CTL response is required for resolution of HBV infection.

[1]  Ruy M Ribeiro,et al.  Hepatitis B virus kinetics and mathematical modeling. , 2004, Seminars in liver disease.

[2]  Simon Wain-Hobson Virus Dynamics: Mathematical Principles of Immunology and Virology , 2001, Nature Medicine.

[3]  Stanca M. Ciupe,et al.  Modeling the mechanisms of acute hepatitis B virus infection. , 2007, Journal of theoretical biology.

[4]  M. Nowak,et al.  Analysis of a cellular model to account for the natural history of infection by the hepatitis B virus and its role in the development of primary hepatocellular carcinoma. , 1992, Journal of theoretical biology.

[5]  Y. Ilan Immune downregulation leads to upregulation of an antiviral response: a lesson from the hepatitis B virus. , 2002, Microbes and infection.

[6]  P. Morel,et al.  Mathematical modeling of immunological reactions. , 1998, Frontiers in bioscience : a journal and virtual library.

[7]  M A Nowak,et al.  The dynamics of hepatitis B virus infection. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. Wodarz Mathematical models of immune effector responses to viral infections: Virus control versus the development of pathology , 2005 .

[9]  Roger Williams,et al.  Role of hepatitis B virus specific cytotoxic T cells in liver damage and viral control. , 2003, Antiviral research.

[10]  M A Nowak,et al.  Viral dynamics in hepatitis B virus infection. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Eva Herrmann,et al.  New kinetic models for the hepatitis C virus , 2005, Hepatology.

[12]  M. Nowak,et al.  A cellular model to explain the pathogenesis of infection by the hepatitis B virus. , 1994, Mathematical biosciences.

[13]  F. Chisari,et al.  Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B. , 2000, The American journal of pathology.

[14]  R. Purcell,et al.  Dynamics of hepatitis B virus clearance in chimpanzees. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Harel Dahari,et al.  Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production. , 2005, Gastroenterology.

[16]  M. Nowak,et al.  Population Dynamics of Immune Responses to Persistent Viruses , 1996, Science.

[17]  G. Sitia,et al.  HBV pathogenesis in animal models: recent advances on the role of platelets. , 2007, Journal of hepatology.

[18]  R. Gieschke,et al.  A Multiphase Model of the Dynamics of HBV Infection in Hbeag-Negative Patients during Pegylated Interferon-α2A, Lamivudine and Combination Therapy , 2005, Antiviral therapy.

[19]  Geoffrey Dusheiko,et al.  The role of cells refractory to productive infection in acute hepatitis B viral dynamics , 2007, Proceedings of the National Academy of Sciences.